Literature DB >> 28087182

Multimorbidity and acute heart failure in internal medicine.

F Martínez1, L Martínez-Ibañez2, G Pichler3, A Ruiz3, J Redon3.   

Abstract

AIMS: To analyse the characteristics of hospitalized patients for AHF, with special attention to the clustering of morbidities. METHODS AND
RESULTS: Clinical records of patients, admitted in Internal Medicine due to AHF, during three years, were reviewed. The characteristics of patients-episodes were registered and key indicators of performance. Multiple correspondence analysis (MCA) was used to assess the distribution of morbidities. LR models were used to study clinical variables related with death or readmission. The median age was 80y, predominantly women and with multiple morbidities. As it was expected, CVRF were the main associated comorbidities followed by respiratory diseases, CKD and chronic anaemia. In the MCA, all the CVRF clustered around the origin so they explained little of the total inertia. Male sex, young age, IHD, obesity and lung disease were more common in reduced EF whereas female, older age and thyroid disease were more common in preserved EF. The confidence ellipses for death in hospitalization or during the follow-up or for readmissions overlapped, so it was not possible to identify clusters of morbidities to predict outcomes. The main causes for AHF were infections, anaemia and RVR in AF. Nearly 16% died during the hospitalization whereas 25.6% died and 56.3% were re-hospitalized during the following year after the discharge. Previous or repeated admissions to the hospital were the best single predictors for death or readmission.
CONCLUSIONS: Strategies to control infections, anaemia and AF, in the outpatient settings, might help to reduce the burden of AHF, although this remains to be proven. Copyright Â
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute heart failure; Death; Hospitalization; Multimorbidity; Prognosis; Readmission

Mesh:

Year:  2017        PMID: 28087182     DOI: 10.1016/j.ijcard.2017.01.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care.

Authors:  Òscar Miró; V Íctor Gil; Francisco Javier Martín-Sánchez; Javier Jacob; Pablo Herrero; Aitor Alquézar; Lluís Llauger; Sira Aguiló; Gemma Martínez; José Ríos; Alberto Domínguez-Rodríguez; Veli-Pekka Harjola; Christian Müller; John Parissis; W Frank Peacock; Pere Llorens
Journal:  Clin Res Cardiol       Date:  2018-03-28       Impact factor: 5.460

2.  Predictive risk factors for death in elderly patients after hospitalization for acute heart failure in an internal medicine unit.

Authors:  Camille Roubille; Benjamin Eduin; Cyril Breuker; Laetitia Zerkowski; Simon Letertre; Cédric Mercuzot; Jonathan Bigot; Guilhem Du Cailar; François Roubille; Pierre Fesler
Journal:  Intern Emerg Med       Date:  2022-04-22       Impact factor: 5.472

3.  Acute kidney injury in heart failure: a population study.

Authors:  Jose Luis Holgado; Cristina Lopez; Antonio Fernandez; Inmaculada Sauri; Ruth Uso; Jose Luis Trillo; Sara Vela; Julio Nuñez; Josep Redon; Adrian Ruiz
Journal:  ESC Heart Fail       Date:  2020-02-14

4.  The impact of subclinical congestion on the outcome of patients undergoing transcatheter aortic valve implantation.

Authors:  Christopher Adlbrecht; Felix Piringer; Jon Resar; Victoria Watzal; Martin Andreas; Andreas Strouhal; Waseem Hasan; Daniela Geisler; Gabriel Weiss; Martin Grabenwöger; Georg Delle-Karth; Markus Mach
Journal:  Eur J Clin Invest       Date:  2020-04-22       Impact factor: 4.686

5.  Impact of Acute Hemoglobin Falls in Heart Failure Patients: A Population Study.

Authors:  Cristina Lopez; Jose Luis Holgado; Antonio Fernandez; Inmaculada Sauri; Ruth Uso; Jose Luis Trillo; Sara Vela; Carlos Bea; Julio Nuñez; Ana Ferrer; Javier Gamez; Adrian Ruiz; Josep Redon
Journal:  J Clin Med       Date:  2020-06-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.